Search

Your search keyword '"Tinea Versicolor pathology"' showing total 148 results

Search Constraints

Start Over You searched for: Descriptor "Tinea Versicolor pathology" Remove constraint Descriptor: "Tinea Versicolor pathology"
148 results on '"Tinea Versicolor pathology"'

Search Results

2. Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and animal skin.

4. MGL_3741 gene contributes to pathogenicity of Malassezia globosa in pityriasis versicolor.

5. MALDI-TOF MS identification of Malassezia species isolated from patients with pityriasis versicolor at the seafarers' medical service in Dakar, Senegal.

6. Tinea Versicolor.

8. Papular eruption in a woman with Down syndrome.

9. Atrophying pityriasis versicolor as an idiosyncratic T cell-mediated response to Malassezia: A case series.

10. Folliculocentric tinea versicolor.

11. [Pityriasis versicolor in infants: unusual clinical presentation and role of corticosteroids used as depigmenting agent for cosmetic purposes in the mother].

12. Clinicomycological profile of pityriasis versicolor in Assam.

16. Malassezia species and their associated skin diseases.

17. A randomized double-blind, non-inferiority Phase II trial, comparing dapaconazole tosylate 2% cream with ketoconazole 2% cream in the treatment of Pityriasis versicolor.

18. Atrophying pityriasis versicolor.

19. Can pityriasis versicolor be treated with 2% ketoconazole foam?

20. Vulvar pityriasis versicolor in an immunocompetent woman.

22. Atypical clinical manifestation of pityriasis versicolor in a young boy.

23. Tinea versicolor in dark-skinned individuals.

24. A case of tinea versicolor of the eyelids.

25. Hair loss in pityriasis versicolor lesions: a descriptive clinicopathological study.

26. Pityriasis versicolor: clinical-epidemiological characterization of patients in the urban area of Buerarema-BA , Brazil.

27. Basic fibroblast growth factor and tumour necrosis factor alpha in vitiligo and other hypopigmented disorders: suggestive possible therapeutic targets.

28. What is your diagnosis? Folliculocentric tinea versicolor.

29. [Pityriasis versicolor].

30. An open-label study of naftifine hydrochloride 1% gel in the treatment of tinea versicolor.

33. Malassezia yeast species isolated from Iranian patients with pityriasis versicolor in a prospective study.

34. Blaschkoid pityriasis versicolor.

35. Pathogenesis of dermatophytosis and tinea versicolor.

36. Single dose (400 mg) versus 7 day (200 mg) daily dose itraconazole in the treatment of tinea versicolor: a randomized clinical trial.

37. Epidemiology of pityriasis versicolor in Adana, Turkey.

38. Extensive tinea versicolor mimicking Pityriasis rubra pilaris.

39. Tinea versicolor with interface dermatitis.

40. A study to evaluate the efficacy and safety of oral fluconazole in the treatment of tinea versicolor.

41. Dermacase. Tinea versicolor.

42. Pityriasis versicolor imbricata--overlapping parallel scales in a novel variant of pityriasis versicolor.

43. Penile shaft involvement in pityriasis versicolor.

44. Uncommon cases of pityriasis versicolor.

45. Malassezia species isolated from lesional and non-lesional skin in patients with pityriasis versicolor.

46. [Malassezia yeasts and their significance in dermatology].

47. [Malassezia related diseases].

48. Hyperkeratotic head and neck Malassezia dermatosis.

49. An unusual presentation of malassezia dermatosis.

50. Sparing of the upper axillary area in pityriasis versicolor.

Catalog

Books, media, physical & digital resources